OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Substance Abuse Treatment is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine	97
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19	90
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder	87
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic	83
A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose	76
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings	74
A systematic review of stigma interventions for providers who treat patients with substance use disorders	73
Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19	71
Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study	64
Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study	62
Peer recovery coaches in general medical settings: Changes in utilization, treatment engagement, and opioid use	50
Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19	50
Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment	47
Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond	46
COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns	46
Family involvement in treatment and recovery for substance use disorders among transition-age youth: Research bedrocks and opportunities	45
Telehealth sustains patient engagement in OUD treatment during COVID-19	43
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island	43
Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19	42
The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19	42
Difficult binds: A systematic review of facilitators and barriers to treatment among mothers with substance use disorders	42
Impacts of COVID-19 on residential treatment programs for substance use disorder	42
Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms	41
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?	39
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis	38

Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic	38
Adolescent substance use: Challenges and opportunities related to COVID-19	36
Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care?	35
“A good mother”: Impact of motherhood identity on women's substance use and engagement in treatment across the lifespan	35
Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine	34
“You have to take this medication, but then you get punished for taking it:” lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period	33
A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations	33
COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings	33